{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:17:41Z","timestamp":1781842661070,"version":"3.54.5"},"reference-count":8,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Background: Diffuse large B cell lymphoma is an aggressive, heterogeneous yet treatable disease. Primary bone lymphoma is a lymphoma involving a single or multiple osseous sites with or without regional nodal involvement. It is exceedingly rare, representing &lt;1% of new non-Hodgkin lymphoma cases per year. Most cases of primary bone lymphoma are diffuse large B cell lymphoma. They infrequently involve the craniofacial bones and mandible; its rarity can lead to delays in diagnosis. Case Series Presentation: Two 64-year-old male patients initially presented to local dentists with concerns of tooth pain and numbness. Both underwent extensive dental procedures including extraction and debridement, with an initial diagnosis of osteomyelitis. They were placed on long-term antibiotics. After months without improvement, further testing was pursued, including imaging and repeat biopsies. The patients were finally diagnosed with primary bone diffuse large B cell lymphoma. From the initial treatment of osteomyelitis, a median time of 8.5 months passed before diagnosis of lymphoma. Treatment with cytotoxic chemotherapy was initiated and both patients achieved remission. Conclusions: As in the two cases presented here, the initial point of entry into the medical system may be a visit to the local dentist. When patients present with periodontal complaints, it is imperative to maintain a broad differential, including lymphoma. This is especially crucial when the patient\u2019s clinical course does not respond to initial treatment. This results in delays of diagnosis and initiation of therapy for a treatable cancer.<\/jats:p>","DOI":"10.3390\/hematolrep18010011","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:16:59Z","timestamp":1769159819000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary Bone Lymphoma of the Jaw Masquerading as Infection and Delaying Treatment"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6401-9120","authenticated-orcid":false,"given":"Emily","family":"Hamburger","sequence":"first","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina, 101 Manning Drive, Chapel Hill, NC 27514, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.","family":"Beaven","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina, 101 Manning Drive, Chapel Hill, NC 27514, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"ref_1","unstructured":"WHO Classification of Tumours Editorial Board (2024). Haematolymphoid Tumours, International Agency for Research on Cancer. [5th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, J., Li, X., Gao, T., Zhou, C., Guo, Q., and Liu, D. (2024). Primary diffuse large B-cell lymphoma of bone in adults: A SEER population-based study. Medicine, 103.","DOI":"10.1097\/MD.0000000000040071"},{"key":"ref_4","unstructured":"Fletcher, C.D.M., Unni, K.K., and Mertens, F. (2002). Pathology and Genetics of Tumors of Soft Tissues and Bone."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijrobp.2011.06.1976","article-title":"Early-stage primary bone lymphoma: A retrospective, multicenter Rare Cancer Network (RCN) Study","volume":"83","author":"Cai","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100326","DOI":"10.1016\/j.jbo.2020.100326","article-title":"Primary bone lymphoma: Clinical presentation and therapeutic considerations","volume":"25","author":"Muller","year":"2020","journal-title":"J. Bone Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Michi, Y., Harada, H., Oikawa, Y., Okuyama, K., Kugimoto, T., Kuroshima, T., Hirai, H., Mochizuki, Y., Shimamoto, H., and Tomioka, H. (2022). Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: A single-center retrospective study. BMC Oral Health, 22.","DOI":"10.1186\/s12903-022-02056-x"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12288-020-01327-3","article-title":"Primary Bone Lymphoma: A 13 year retrospective institutional analysis in the chemo-immunotherapy era","volume":"37","author":"Sharma","year":"2020","journal-title":"Indian J. Hematol. Blood Transfus."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:51:11Z","timestamp":1769161871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/18\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["hematolrep18010011"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep18010011","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}